MK0767

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for MK0767, covering 2015-02-10 to 2015-06-23. Get the full timeline:

Most recent: Clinical Trial Update: MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030) [Phase 3]